Q: Where is Tokai Pharmaceuticals headquartered?
A: Tokai is headquartered at 225 State Street, 6th Floor, Boston, MA 02109. The main phone number is (617) 225-4305.
Q: When was Tokai Pharmaceuticals founded?
A: Tokai was incorporated in 2004 in the state of Delaware.
Q: How is Tokai Pharmaceuticals’ stock traded?
A: Tokai is traded on the NASDAQ Global Market under the ticker symbol TKAI and its CUSIP number is 88907J 107.
Q: How can I purchase shares of Tokai Pharmaceuticals' stock?
A: Shares of TKAI can be purchased through a stockbroker of your choice.
Q: When is Tokai Pharmaceuticals’ fiscal year-end?
A: December 31st.
Q: Who is the transfer agent for Tokai Pharmaceuticals?
A: Continental Stock Transfer & Trust
Phone: (212) 845-3224
17 Battery Place, 8th Floor
New York, NY 10004
Q: Who is Tokai Pharmaceuticals’ independent auditor?
A: PricewaterhouseCoopers, LLP
125 High Street
Boston, MA 02110
Q: Where can I view Tokai Pharmaceuticals’ corporate news releases?
A: Tokai’s press release archives can be accessed in the Press Releases section.
Q: Where can I view documents that Tokai Pharmaceuticals has filed with the Securities & Exchange Commission (SEC)?
Q: Who should I contact if I have further questions?
A: You can submit queries to Tokai’s investor relations department by contacting firstname.lastname@example.org.
|Print Page | E-mail Page | RSS Feeds | E-mail Alerts | IR Contacts | Financial Tear Sheet|